A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.

@article{Smit2017APR,
  title={A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public.},
  author={Amelia K Smit and David Espinoza and Ainsley J Newson and Rachael L Morton and Georgina L Fenton and Lucinda Freeman and Kate L. Dunlop and Phyllis Butow and Matthew H Law and Michael G Kimlin and Louise A Keogh and Suzanne Jane Dobbinson and Judy Kirk and Peter A. Kanetsky and Graham J. Mann and Anne E Cust},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  year={2017},
  volume={26 2},
  pages={212-221}
}
BACKGROUND Communication of personalized melanoma genomic risk information may improve melanoma prevention behaviors. METHODS We evaluated the feasibility and acceptability of communicating personalized genomic risk of melanoma to the public and its preliminary impact on behaviors and psychosocial outcomes. One hundred eighteen people aged 22 to 69 years provided a saliva sample and were randomized to the control (nonpersonalized educational materials) or intervention (personalized booklet… CONTINUE READING
Highly Cited
This paper has 26 citations. REVIEW CITATIONS

From This Paper

Figures and tables from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 53 references

Similar Papers

Loading similar papers…